High-intensity Exercise After Acute Cardiac Event (HITCARE)
Keywords
Abstract
Description
The study population consists of patients living in the city of Kuopio or Siilinjarvi area in Eastern Finland, who have been treated in Kuopio University Hospital because of acute CAD event. After baseline measurements, the patients will be randomized into one of the 3 groups: short interval HIT protocol (HIT-S), long interval HIT protocol (HIT-L) or UC group. The intervention will be 12 months per patient and the expected duration of the whole study (intervention data collection) is estimated to be 4 years. In addition, all groups will have annual follow-up examinations scheduled up to 60 months after initiation of the intervention phase. The patients recruited for the study will be 750, a total of 250 patients per study group.
All measurements related to intervention will be performed at Kuopio Research Institute of Exercise Medicine. Examinations concerning myocardial structure and perfusion will be done at Turku PET Center (subsample).
The study complies with the Helsinki declaration, follows good clinical practice. Patient safety will follow normal medical practice. The intervention is not anticipated to cause health risks apart from the conventional treatment. All participants will be provided with diverse individualized information about their health and physical performance. The research methods employed in the study are safe. Physician and nurse will be present at each occasion when physically strenuous measurements are performed and careful provisions for appropriate first aid will be made. The measurements assessing cardiorespiratory and muscular fitness will involve hard effort and it is not unusual to feel innocent muscle pain for a few days after measurements demanding maximal effort. The other potential acute complications may include accidents (e.g. injuries due to slipping or falling) and medical emergencies like acute myocardial infarction.
Study hypotheses:
1. Short (15 sec) and long interval (3 min) high-intensity aerobic interval training (HIT) combined with resistance training after acute CAD event are equally effective in improving cardiorespiratory fitness compared with UC.
2. Despite higher unit costs, the differences in health-related quality of life effects are so large that both HIT interventions are cost-effective compared with UC.
3. Patient's experiences and interpretation of HIT exercise as well as different social processes during rehabilitation explain the cost-effectiveness of the rehabilitation.
4. Patient groups who will or will not benefit of HIT interventions can be identified and predicted.
Dates
| Last Verified: | 11/30/2015 |
| First Submitted: | 09/02/2014 |
| Estimated Enrollment Submitted: | 09/07/2014 |
| First Posted: | 09/09/2014 |
| Last Update Submitted: | 01/22/2017 |
| Last Update Posted: | 01/23/2017 |
| Actual Study Start Date: | 11/30/2014 |
| Estimated Primary Completion Date: | 11/13/2016 |
| Estimated Study Completion Date: | 11/30/2019 |
Condition or disease
Intervention/treatment
Behavioral: High-intensity interval training, HIT-S
Behavioral: High-intensity interval training, HIT-L
Phase
Arm Groups
| Arm | Intervention/treatment |
|---|---|
| Experimental: High-intensity interval training, HIT-S High-intensity aerobic interval training, short interval (HIT-S) | Behavioral: High-intensity interval training, HIT-S The intensity of HIT-S sessions (cycle ergometer) will be increased during 3 to 6 months from 60% of VO2peak to 100% which will be the target intensity from 6 to 12 months. The protocol includes four 6 min sets consisting of 15 sec exercise followed by 15 sec passive recovery separated with 3 min passive recovery between sets. Exercise session will last ca. 40 min, with 12 min of HIT, warm-up and recovery. The intensity of the 15 seconds exercise bouts will be based on VO2peak at baseline and after 6 months. Meanwhile, the estimated VO2peak from the submaximal test will be used to adjust the training intensity in HIT sessions. Training will be conducted in a group of 1-3 HIT-S patients with ECG monitoring and supervised by physician. |
| Experimental: High-intensity interval training, HIT-L High-intensity aerobic interval training, long interval (HIT-L) | Behavioral: High-intensity interval training, HIT-L The intensity of HIT-L sessions (cycle ergometer) will be increased during 3 to 6 months from 60% of VO2peak to 90% which will be the target intensity from 6 to 12 months. The protocol includes four 3 min exercise bouts with a 4 min recovery (pedaling at 0 W) between bouts. Exercise session will last ca. 40 min, with 12 min of HIT, warm-up and recovery. The intensity of the 3 min exercise bouts will be based on VO2peak at baseline and after 6 months. Meanwhile, the estimated VO2peak from the submaximal test will be used to adjust the training intensity in HIT sessions. Training will be conducted in a group of 1-3 HIT-L patients with ECG monitoring and supervised by physician. |
| No Intervention: Usual care control group |
Eligibility Criteria
| Ages Eligible for Study | 40 Years To 40 Years |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: - hospital care after acute CAD event (ICD-10 codes I20.0-I22) - age 40-80 years - signed informed consent form Exclusion Criteria: - conditions preventing regular exercise training - severe/malignant disease (life expectancy <12 months) |
Outcome
Primary Outcome Measures
1. Change in cardiorespiratory fitness as assessed by peak oxygen uptake (VO2peak) [Baseline, 6 and 12 months]
Secondary Outcome Measures
1. Incremental health care cost/quality-adjusted life-year-relation [Baseline, 6 and 12 months]
2. Social processes explaining adherence and motivation to exercise rehabilitation [Baseline, 6 and 12 months]
3. Total costs of the use of health care services [Baseline, 6 and 12 months]
4. Utilization of health care resources [Baseline, 6 and 12 months]
5. Change in health-related quality of life [Baseline, 6 and 12 months]
Other Outcome Measures
1. Change in ergospirometer variables [Baseline, 6 and 12 months]
2. Change in muscular performance [Baseline, 6 and 12 months]
3. Change in daily energy expenditure [Baseline, 6 and 12 months]
4. Sleeping time [Baseline, 6 and 12 months]
5. Sitting time [Baseline, 6 and 12 months]
6. Dietary habits [Baseline, 6 and 12 months]
7. Change in chest pain symptoms, exercise induced angina or ischemia [Baseline, 6 and 12 months]
8. Change in antianginal and other medication [Baseline, 6 and 12 months]
9. Hospitalization due to cardiovascular causes [Baseline, 6 and 12 months]
10. Change in vascular risk factors [Baseline, 6 and 12 months]
11. Progression of peripheral atherosclerosis [Baseline, 6 and 12 months]
12. Change in cognitive function [Baseline and 12 months]
13. Change in depressive symptoms [Baseline, 6 and 12 months]
14. Intervention related adverse events [Throughout the intervention phase]
15. Change in myocardial blood flow capacity and left ventricular function [Baseline and 12 months]
16. Change in myocardial blood flow at rest and during adenosine infusion [Baseline and 12 months]
17. Change in myocardial blood flow reserve [Baseline and 12 months]
18. Change in left ventricular ejection fraction [Baseline and 12 months]
19. Change in left ventricular longitudinal peak systolic strain [Baseline and 12 months]
20. Change in left mitral annular diastolic tissue velocity [Baseline and 12 months]
21. Change in autonomic nervous system control of cardiac function [Baseline and 12 months]
22. Change in body composition [Baseline, 6 and 12 months]
23. Change in anthropometric measures [Baseline, 6 and 12 months]
24. All-cause death [Baseline, 6 and 12 months; annual follow-up up to 60 months]
25. Cardiovascular death [Baseline, 6 and 12 months; annual follow-up up to 60 months]
